US Urges Justices Not To Review Drug Exec's $1M Tax Penalty

By David Hansen · May 16, 2023, 6:35 PM EDT

The U.S. Supreme Court should not accept a drug company executive's challenge to lower courts' findings that there is an objective standard for his reckless failure to report foreign bank accounts,...

To view the full article, register now.